C44 - Multiple Sclerosis Therapy: Symptom Management
| Event Time: | Sunday May 5, 2019 7:00 am to 9:00 am |
| Topic(s): | MS and CNS Inflammatory Disease, Foundations in Clinical Neurology for APPs |
| Director(s): | Andrew Solomon MD, FAAN |
| Description: | Symptom management in MS remains a very important determinant of quality of life in MS patients, even with the advent of increasing numbers of MS disease-modifying therapies. Symptoms of MS may be under-recognized and there are knowledge gaps among neurologists regarding management of these common symptoms. Faculty will review the management of common MS symptoms including fatigue, spasticity, neuropathic pain, bladder problems, bowel problems, and sexual dysfunction, and conclude with an open panel discussion regarding management of these and other commonly encountered symptoms in MS patients. |
| Completion Message: | Participants should be able to diagnose and treat symptoms of fatigue, spasticity, neuropathic pain, bladder and bowel symptoms, and sexual dysfunction in MS patients. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 7:00 AM - 7:10 AM | Introduction | Andrew Solomon MD, FAAN |
| 7:10 AM - 7:30 AM | Spasticity | Mary Alissa Willis MD |
| 7:30 AM - 7:50 AM | Fatigue | Andrew Solomon MD, FAAN |
| 7:50 AM - 8:10 AM | Neuropathic Pain | Edward Kim MD |
| 8:10 AM - 8:30 AM | Bladder, Bowel, and Sexual Dysfunction | Jacqueline Ann Nicholas MD |
| 8:30 AM - 9:00 AM | Management of MS Symptoms: Open Panel Discussion | Edward Kim MD, Jacqueline Ann Nicholas MD, Andrew Solomon MD, FAAN, Mary Alissa Willis MD |
| Speaker | Disclosure |
|---|---|
| Edward Kim, MD | Dr. Kim has nothing to disclose. |
| Jacqueline Ann Nicholas, MD | Dr. Nicholas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, EMD Serono, Medtronic, Novartis Pharmaceuticals, Sanofi Genzyme, and Teva. Dr. Nicholas has received research support from Biogen, Novartis Pharmaceuticals, and Sanofi. |
| Andrew Solomon, MD, FAAN | Dr. Solomon has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, EMD Serono. Dr. Solomon has received research support from Biogen. |
| Mary Alissa Willis, MD | Dr. Willis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Genzyme, Novartis, Ipsen. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
|
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
S56 -
MS Trials and Treatment
|
| 3:30 PM-4:30 PM |
|
C257 -
Education Blitz: Evolution of Autoimmune Neurology
Steven Vernino MD, PhD, FAAN |
|
C258 -
Education Blitz: Multiple Sclerosis
Stephen Krieger MD, FAAN |